Literature DB >> 10400046

Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver.

M M Uggowitzer1, C Kugler, H J Mischinger, R Gröll, A Ruppert-Kohlmayr, K W Preidler, F Quehenberger.   

Abstract

Lesions of focal nodular hyperplasia are hypervascular, benign focal liver lesions whose differentiation from other focal liver lesions is of significant clinical relevance. The purpose of this study was to investigate the echo-enhancing agent SHU 508A (Levovist) in the evaluation of focal nodular hyperplasia with Doppler sonography. We examined 49 patients with 71 lesions of focal nodular hyperplasia in the liver with gray scale and power Doppler sonography. In all patients Levovist was administered intravenously in a concentration of 300 to 400 mg galactose per milliliter. Visualization of the feeding vessels and the vascularity of the lesions were evaluated, and the resistive indices in the feeders and the hepatic arteries were assessed. In comparison with unenhanced power Doppler sonography, echo-enhanced power Doppler sonography yields a higher sensitivity in the detection of the feeding artery (97% versus 82%) in focal nodular hyperplasia and in the depiction of the radial vascular architecture in such lesions, especially those located in the left lobe of the liver. Lesions less than 3 cm in diameter do not consistently show a characteristic vascular architecture with echo-enhanced Doppler sonography. The resistive index of the tumor-feeding artery (mean, 0.51 +/- 0.09) is significantly (P < 0.0001) lower than that of the hepatic artery (mean, 0.65 +/- 0.06) and decreases as the size of the focal nodular hyperplasia increases. The administration of Levovist may improve the signal-to-noise ratio and thus visualization of the vascular architecture in focal nodular hyperplasia. Lesions located in the left lobe of the liver, which commonly are subject to disturbing motion artifacts in color Doppler sonography, will significantly benefit from the administration of Levovist. Echo-enhanced power Doppler sonography, however, is not capable of depicting a characteristic vascular pattern in small (< or = 3 cm) lesions of focal nodular hyperplasia that would guarantee a specific diagnosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400046     DOI: 10.7863/jum.1999.18.7.445

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  6 in total

Review 1.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

2.  Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Emilio Quaia; Michele Bertolotto; Massimo Galia; Filippo Cademartiri; Roberto Lagalla; Adelfio Elio Cardinale
Journal:  Eur Radiol       Date:  2005-02-15       Impact factor: 5.315

Review 3.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

4.  Focal nodular hyperplasia: with a focus on contrast enhanced ultrasound.

Authors:  Ho Suk Kang; Byung Kook Kim; Chan Sup Shim
Journal:  Korean J Hepatol       Date:  2010-12

5.  Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Michele Scialpi; Elio Sciarrino; Massimo Galia; Roberto Lagalla
Journal:  Eur Radiol       Date:  2003-10-10       Impact factor: 5.315

6.  Diagnosis and management of hepatic focal nodular hyperplasia.

Authors:  A Venturi; F Piscaglia; G Vidili; S Flori; R Righini; R Golfieri; L Bolondi
Journal:  J Ultrasound       Date:  2007-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.